Equity, diversity & inclusion (EDI)

The Society is proud of its friendly, vibrant, professional and supportive community. We seek to represent and be inclusive of people from a wide variety of backgrounds across the communities we serve.

We provide a supportive environment within our Society that celebrates achievements and provides encouragement when things don’t go to plan. We are working to remove systemic barriers to participation that may be faced by existing or potential members – such as participation in Society committees and groups, attending events, publishing in our journals, and receiving recognition through our prizes and awards.

We contribute to and advance wider discussions about equity, diversity and inclusion. This includes collaborating with our partners in the sector to support widening participation, positive research culture, and inclusive research and experimental design. We support, learn and actively seek opportunities to make a larger impact.

The Society recognises that, historically, pharmacological research hasn't been inclusive in terms of who benefits from it. While things are improving, there is still work to be done.

We believe that we have a better chance of improving health and social challenges if a diverse mix of people is involved in research and decision-making (see section above).

We embed EDI principles into our criteria for scientific content shared at our meetings and events to help everyone benefit from the outcomes of pharmacology research. Our

• Ensuring that research and trials take into consideration sex, race, socioeconomic status, and other characteristics as experimental variables that may affect how different patients react to the same medication.
• Further exploring pharmacogenomics/pharmacogenetics (PGx) - the study of how an individual's genetics determines which medicine will provide them the best health outcome.

The Society is committed to being an inclusive employer. We will continue to evolve our approach to inclusive recruitment, staff support and development, and a positive organisational culture.

The Society seeks to represent, and be inclusive of, people from a wide variety of backgrounds across the communities we serve. We are proud of our friendly, vibrant, professional and supportive community. We will provide a supportive environment within our Society that celebrates achievements and provides encouragement when things don’t go to plan. We will remove systemic barriers to participation that may be faced by existing or potential members – such as participation in Society committees and groups, and recognition through our prizes and awards.

The Society is committed to being an inclusive employer. We will continue to evolve our approach to inclusive recruitment, staff support and development, and a positive organisational culture.  

The Society disseminates pharmacological research through our journals and meetings. We will ensure our publication and review processes are inclusive, fair, and support participation from a diverse range of people across the sector. We will work with our journals, and through our meetings and events to continue to set and communicate inclusive standards for research and practice, and the decisions we make about our commissioning. We will also embed EDI into our criteria for scientific content shared at our meetings and events to help everyone benefit from the outcomes of pharmacology research.

We provide education and training, delivering the UK national prescribing assessment alongside a national and international programme of continuing professional development through workshops, e-learning and assessment, and supporting our community of educators through curricula and networks. We will work to ensure education and training content developed by the Society is accessible and that it addresses equality, diversity and inclusion in its content where relevant. We will work with educators and institutions to help ensure pharmacology education, training and engagement is open and accessible to all (including diversifying and decolonising curricula), with the ambition of widening participation.

The Society is part of a wider scientific community including funders, employers, professional bodies and other learned societies. We will contribute to – and advance - wider discussions about equality, diversity and inclusion and collaborate with our partners in the sector to support widening participation, positive research culture, and inclusive research and experimental design - supporting and learning from them, and actively seeking opportunities to make a larger impact.